Industry News

May 30, 2018
By BioPharm International Editors
World Health Organization’s Ebola ring vaccination uses Merck & Co.’s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.
May 30, 2018
By BioPharm International Editors
FDA sent a warning letter to Jilin Shulan Synthetic Pharmaceutical Co., Ltd. after an inspection found CGMP violations including a lack of data integrity.
May 30, 2018
By BioPharm International Editors
The new draft guidance addresses the premarketing assessment of a drug’s effect on blood pressure.
May 23, 2018
Right-to-Try bill sent to White House for President’s signature after passage by Congress.
May 17, 2018
By BioPharm International Editors
Internationalization and regulatory reform are driving growth and investment China.
May 17, 2018
By BioPharm International Editors
The FDA commissioner released a statement expressing the agency’s plan to address tactics used by pharma companies to delay generic-drug competition.
May 17, 2018
By BioPharm International Editors
Representatives from the two pharmacopeias held a symposium on European and Indian legislation and regulatory requirements regarding the quality of drugs.
May 16, 2018
By BioPharm International Editors
ExcipientFest has been acquired by IPEC and rebranded as Excipient World.
May 16, 2018
By BioPharm International Editors
The company is recalling Piperacillin and Tazobactam for injection, USP 3.375 g because of glass particulates found in a vial.
May 16, 2018
By BioPharm International Editors
The company is recalling Piperacillin and Tazobactam for Injection, USP 3.375 Gram/Vial And 4.5 Gram/Vial strengths because of concerns of decreased potency due to elevated levels of impurities.
native1_300x100
lorem ipsum